{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,24]],"date-time":"2026-07-24T11:52:25Z","timestamp":1784893945327,"version":"3.55.0"},"reference-count":34,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"25","license":[{"start":{"date-parts":[[2021,6,25]],"date-time":"2021-06-25T00:00:00Z","timestamp":1624579200000},"content-version":"unspecified","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc\/4.0"}],"content-domain":{"domain":["lww.com","ovid.com"],"crossmark-restriction":true},"short-container-title":[],"abstract":"<jats:title>Abstract<\/jats:title>\n          <jats:sec>\n            <jats:title>Background:<\/jats:title>\n            <jats:p>Antiphospholipid antibody syndrome (APS) is a systemic, autoimmune, prothrombotic disease characterized by persistent antiphospholipid antibodies, thrombosis, recurrent abortion, complications during pregnancy, and occasionally thrombocytopenia. At present, there is no consensus on the treatment of this disease. Long-term anticoagulation is recommended in most cases in patients with thrombotic APS. This study aimed to evaluate whether aspirin combined with low-molecular-weight heparin (LMWH) can improve the live birth rate in antiphospholipid syndrome and its correlation with D-dimer.<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>Methods:<\/jats:title>\n            <jats:p>The data were retrieved from the WanFang Data, CBM, VIP, CNKI, the Cochrane Library, PubMed, EMBASE, OVID, and Web of Science databases. We collected data on randomized controlled trials of aspirin combined with LMWH in the treatment of pregnant women with APS. The \u201cRisk of Bias Assessment\u201d tool and the \u201cJadad Scale\u201d provided by the Cochrane Collaboration were used to evaluate the risk of bias and quality of the collected literature. The risk ratio (RR) and its 95% confidence interval (CI) were determined using Statase-64 software.<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>Results:<\/jats:title>\n            <jats:p>In this study, a total of 11 studies were included, comprising a total of 2101 patients. The live birth rate in pregnant women with APS was higher on administration of aspirin combined with LMWH than with aspirin alone (RR\u200a=\u200a1.29, 95% CI\u200a=\u200a1.22\u20131.35, <jats:italic toggle=\"yes\">P<\/jats:italic> &lt; .001). <jats:sc>d<\/jats:sc>-dimer concentration in plasma predicted the live birth rate, which was higher below the baseline than above it (RR\u200a=\u200a1.16, 95% CI\u200a=\u200a1.09\u20131.23, <jats:italic toggle=\"yes\">P<\/jats:italic>\u200a&lt;\u200a.001). The subgroup analysis of the live birth rate was carried out based on the course of treatment, and the results were consistent with the overall results. Begg funnel plot test revealed no publication bias. Sensitivity analysis showed that deleting any study did not affect the results.<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>Conclusion:<\/jats:title>\n            <jats:p>Aspirin combined with LMWH for APS may improve live birth rate, and detection of <jats:sc>d<\/jats:sc>-dimer levels in APS pregnant women may predict pregnancy complications and guide the use of anticoagulants.<\/jats:p>\n          <\/jats:sec>","DOI":"10.1097\/md.0000000000026264","type":"journal-article","created":{"date-parts":[[2021,6,23]],"date-time":"2021-06-23T13:44:28Z","timestamp":1624455868000},"page":"e26264","update-policy":"https:\/\/doi.org\/10.1097\/lww.0000000000001000","source":"Crossref","is-referenced-by-count":11,"title":["Meta-analysis on aspirin combined with low-molecular-weight heparin for improving the live birth rate in patients with antiphospholipid syndrome and its correlation with d-dimer levels"],"prefix":"10.1097","volume":"100","author":[{"given":"Ting","family":"Shi","sequence":"first","affiliation":[{"name":"The Department of Blood Transfusion"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zhong-Deng","family":"Gu","sequence":"additional","affiliation":[{"name":"The Department of Rehabilitation"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Qi-zhi","family":"Diao","sequence":"additional","affiliation":[{"name":"The Department of Clinical Laboratory Medicine, Yongchuan Hospital, Chongqing Medical University, Yongchuan, Chongqing, China."}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"276","published-online":{"date-parts":[[2021,6,25]]},"reference":[{"key":"R1-20250504","doi-asserted-by":"crossref","first-page":"621","DOI":"10.1055\/s-0039-1697982","article-title":"Antiphospholipid antibody syndrome and infertility","volume":"41","author":"Rodrigues","year":"2019","journal-title":"Rev Bras Ginecol Obstet"},{"key":"R2-20250504","first-page":"956","article-title":"Diagnosis and treatment of antiphospholipid antibody-related recurrent spontaneous abortion and analysis of therapeutic drugs and pregnancy outcome in 75 patients with antiphospholipid syndrome","volume":"50","author":"Li","year":"2018","journal-title":"Beijing Da Xue Bao Yi Xue Ban"},{"key":"R3-20250504","doi-asserted-by":"crossref","first-page":"1207","DOI":"10.1556\/OH.2012.29425","article-title":"Antiphospholipid syndrome and pregnancy","volume":"153","author":"Gad\u00f3","year":"2012","journal-title":"Orv Hetil"},{"key":"R4-20250504","doi-asserted-by":"crossref","first-page":"2111","DOI":"10.1007\/s10067-020-05183-4","article-title":"Management of antiphospholipid syndrome","volume":"39","author":"Rahman","year":"2020","journal-title":"Clin Rheumatol"},{"key":"R5-20250504","doi-asserted-by":"crossref","first-page":"281","DOI":"10.1016\/j.autrev.2013.10.014","article-title":"Efficacy of aspirin for the primary prevention of thrombosis in patients with antiphospholipid antibodies: an international and collaborative meta-analysis","volume":"13","author":"Arnaud","year":"2014","journal-title":"Autoimmun Rev"},{"key":"R6-20250504","doi-asserted-by":"crossref","first-page":"2382","DOI":"10.1002\/art.22663","article-title":"Aspirin for primary thrombosis prevention in the antiphospholipid syndrome: a randomized, double-blind, placebo-controlled trial in asymptomatic antiphospholipid antibody-positive individuals","volume":"56","author":"Erkan","year":"2007","journal-title":"Arthritis Rheum"},{"key":"R7-20250504","doi-asserted-by":"crossref","first-page":"795","DOI":"10.1016\/j.autrev.2014.02.003","article-title":"14th International Congress on Antiphospholipid Antibodies Task Force report on obstetric antiphospholipid syndrome","volume":"13","author":"de Jesus","year":"2014","journal-title":"Autoimmun Rev"},{"key":"R8-20250504","first-page":"CD012852","article-title":"Aspirin or heparin or both for improving pregnancy outcomes in women with persistent antiphospholipid antibodies and recurrent pregnancy loss","volume":"5","author":"Hamuly\u00e1k","year":"2020","journal-title":"Cochrane Database Syst Rev"},{"key":"R9-20250504","first-page":"280","article-title":"Use of D-dimer in biological control of pregnancy","volume":"13","author":"Otero","year":"2015","journal-title":"J Thromb Haemost"},{"key":"R10-20250504","doi-asserted-by":"crossref","first-page":"01","DOI":"10.1016\/0197-2456(95)00134-4","article-title":"Assessing the quality of reports of randomized clinical trials: is blinding necessary?","volume":"17","author":"Jadad","year":"1996","journal-title":"Control Clin Trials"},{"key":"R11-20250504","doi-asserted-by":"crossref","first-page":"d5928","DOI":"10.1136\/bmj.d5928","article-title":"The Cochrane Collaboration's tool for assessing risk of bias in randomised trials","volume":"343","author":"Higgins","year":"2011","journal-title":"BMJ (Clin Res Ed)"},{"key":"R12-20250504","doi-asserted-by":"crossref","first-page":"13","DOI":"10.1186\/1471-2288-5-13","article-title":"Estimating the mean and variance from the median, range, and the size of a sample","volume":"5","author":"Hozo","year":"2005","journal-title":"BMC Med Res Methodol"},{"key":"R13-20250504","doi-asserted-by":"crossref","first-page":"557","DOI":"10.1136\/bmj.327.7414.557","article-title":"Measuring inconsistency in meta-analyses","volume":"327","author":"Higgins","year":"2003","journal-title":"BMJ (Clin Res Ed)"},{"key":"R14-20250504","doi-asserted-by":"crossref","first-page":"e1000097","DOI":"10.1371\/journal.pmed.1000097","article-title":"Preferred Reporting Items for Systematic Reviews and Meta-Analyses: the PRISMA statement","volume":"6","author":"Moher","year":"2009","journal-title":"PLoS Med"},{"key":"R15-20250504","first-page":"66","article-title":"D-dimer assay may guide LMWH treatment in repeated biochemical pregnancy losses in women with positive antiphospholipid antibody","author":"Bao","year":"2020","journal-title":"Clin Lab"},{"key":"R16-20250504","first-page":"374","article-title":"Therapeutic effect of 50 pregnancy patients with antiphospholipid syndrome","volume":"32","author":"Deng","year":"2012","journal-title":"J Gannan Med Coll"},{"key":"R18-20250504","first-page":"27","article-title":"Clinical efficacy of aspirin combined with LMWH in the treatment of recurrent abortion induced by anti-phospholipid antibodies","volume":"52","author":"Yanli","year":"2020","journal-title":"J Qingdao Med Health Sci"},{"key":"R19-20250504","first-page":"139","article-title":"The effect of low molecular weight heparin on the treatment of recurrent abortion caused by anti-phospholipid antibody syndrome","volume":"14","author":"Yongqin","year":"2016","journal-title":"J Contemp Med"},{"key":"R20-20250504","first-page":"369","article-title":"Clinical study on the treatment of recurrent abortion caused by anti-phospholipid antibody syndrome with aspirin and low molecular weight heparin","volume":"10","author":"Linchun","year":"2020","journal-title":"Doctors"},{"key":"R21-20250504","first-page":"60","article-title":"Aspirin and low molecular weight heparin in the treatment of chronic abortion and antiphospholipid syndrome","volume":"50","author":"Wang","year":"2012","journal-title":"China Mod Phys"},{"key":"R22-20250504","doi-asserted-by":"crossref","first-page":"e12770","DOI":"10.1111\/aji.12770","article-title":"Use of D-dimer measurement to guide anticoagulant treatment in recurrent pregnancy loss associated with antiphospholipid syndrome","volume":"78","author":"Bao","year":"2017","journal-title":"Am J Reprod Immunol"},{"key":"R23-20250504","doi-asserted-by":"crossref","first-page":"509","DOI":"10.1177\/096120339700600606","article-title":"Obstetric outcome in antiphospholipid syndrome","volume":"6","author":"Granger","year":"1997","journal-title":"Lupus"},{"key":"R24-20250504","doi-asserted-by":"crossref","first-page":"279","DOI":"10.3899\/jrheum.080763","article-title":"Low molecular weight heparin and aspirin for recurrent pregnancy loss: results from the randomized, controlled HepASA Trial","volume":"36","author":"Laskin","year":"2009","journal-title":"J Rheumatol"},{"key":"R25-20250504","doi-asserted-by":"crossref","first-page":"176","DOI":"10.1016\/j.mefs.2013.12.004","article-title":"Enoxaparin and aspirin therapy for recurrent pregnancy loss due to anti-phospholipid syndrome (APS)","volume":"19","author":"Mohamed","year":"2014","journal-title":"Middle East Fertil Soc J"},{"key":"R26-20250504","doi-asserted-by":"crossref","first-page":"1800","DOI":"10.1056\/NEJM200206063462309","article-title":"Cost effectiveness of aspirin, clopidogrel, or both for secondary prevention of coronary heart disease","volume":"346","author":"Gaspoz","year":"2002","journal-title":"N Engl J Med"},{"key":"R27-20250504","doi-asserted-by":"crossref","first-page":"e16883","DOI":"10.1097\/MD.0000000000016883","article-title":"Comparison of 2 approaches in management of pregnant women with inherited trombophilias: prospective analytical cohort study","volume":"98","author":"Dugalic","year":"2019","journal-title":"Medicine (Baltimore)"},{"key":"R28-20250504","first-page":"01","article-title":"Combined hereditary thrombophilias are responsible for poor placental vascularization development and low molecular weight heparins (LMWH) prevent adverse pregnancy outcomes in these patients","volume":"18","author":"Gojnic","year":"2020","journal-title":"J Matern Fetal Neonatal Med"},{"key":"R29-20250504","doi-asserted-by":"crossref","first-page":"1819","DOI":"10.1007\/s40265-017-0823-0","article-title":"Aspirin for prevention of preeclampsia","volume":"77","author":"Atallah","year":"2017","journal-title":"Drugs"},{"key":"R30-20250504","first-page":"CD002859","article-title":"Prevention of recurrent miscarriage for women with antiphospholipid antibody or lupus anticoagulant","volume":"18","author":"Empson","year":"2005","journal-title":"Cochrane Database Syst Rev"},{"key":"R31-20250504","doi-asserted-by":"crossref","first-page":"408","DOI":"10.1097\/00006250-200212000-00032","article-title":"Antiphospholipid syndrome in pregnancy: a randomized, controlled trial of treatment","volume":"100","author":"Farquharson","year":"2002","journal-title":"Obstet Gynecol"},{"key":"R32-20250504","doi-asserted-by":"crossref","first-page":"1256","DOI":"10.1097\/AOG.0b013e3181deba40","article-title":"Heparin treatment in antiphospholipid syndrome with recurrent pregnancy loss: a systematic review and meta-analysis","volume":"115","author":"Ziakas","year":"2010","journal-title":"Obstet Gynecol"},{"key":"R33-20250504","doi-asserted-by":"crossref","first-page":"488","DOI":"10.1182\/blood.V114.22.488.488","article-title":"Aspirin and aspirin combined with low-molecular-weight heparin in women with unexplained recurrent miscarriage: a randomized controlled multicenter trial (ALIFE study)","volume":"114","author":"Kaandorp","year":"2009","journal-title":"Blood"},{"key":"R34-20250504","doi-asserted-by":"crossref","first-page":"161","DOI":"10.1016\/j.ijgo.2015.04.049","article-title":"Prothrombotic state of patients with unexplained recurrent spontaneous abortion","volume":"131","author":"Lu","year":"2015","journal-title":"Int J Gynaecol Obstet"},{"key":"R35-20250504","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1191\/0961203302lu132oa","article-title":"Fluctuations in levels of antiphospholipid antibodies and increased coagulation activation markers in normal and heparin-treated antiphospholipid syndrome pregnancies","volume":"11","author":"Donohoe","year":"2002","journal-title":"Lupus"}],"container-title":["Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/journals.lww.com\/10.1097\/MD.0000000000026264","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,5,4]],"date-time":"2025-05-04T06:05:35Z","timestamp":1746338735000},"score":1,"resource":{"primary":{"URL":"https:\/\/journals.lww.com\/10.1097\/MD.0000000000026264"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,6,25]]},"references-count":34,"journal-issue":{"issue":"25","published-online":{"date-parts":[[2021]]}},"URL":"https:\/\/doi.org\/10.1097\/md.0000000000026264","relation":{},"ISSN":["0025-7974","1536-5964"],"issn-type":[{"value":"0025-7974","type":"print"},{"value":"1536-5964","type":"electronic"}],"subject":[],"published":{"date-parts":[[2021,6,25]]},"assertion":[{"value":"2020-12-28","name":"received","label":"Received","group":{"name":"publication_history","label":"Publication History"}},{"value":"2021-05-22","name":"accepted","label":"Accepted","group":{"name":"publication_history","label":"Publication History"}}]}}